(Q38187331)

30 August 2017

title

The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift (English)

1 reference

30 August 2017

1 reference

1 reference

1 reference

Clare J Reade

1

1 reference

30 August 2017

Ruaidhrí M McVey

2

1 reference

30 August 2017

Alicia A Tone

3

1 reference

30 August 2017

Sarah J Finlayson

4

1 reference

30 August 2017

Jessica N McAlpine

5

1 reference

30 August 2017

Michael Fung-Kee-Fung

6

1 reference

30 August 2017

Sarah E Ferguson

7

1 reference

30 August 2017

publication date

1 February 2014

1 reference

Journal of Obstetrics and Gynaecology Canada

30 August 2017

published in

1 reference

30 August 2017

volume

36

1 reference

30 August 2017

issue

2

1 reference

30 August 2017

page(s)

133-140

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

30 August 2017

1 reference

7 January 2021

Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Modeling high-grade serous ovarian carcinogenesis from the fallopian tube

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Ovarian cancer incidence and survival by histologic type in Osaka, Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or -2 mutations: implications for gross examination, cytology, and clinical follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

New insights into the pathogenesis of serous ovarian cancer and its clinical impact

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Risks and benefits of screening asymptomatic women for ovarian cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Effect of Screening on Ovarian Cancer Mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Risk-reducing salpingectomy in Canada: a survey of obstetrician-gynaecologists

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes?

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

The distal fallopian tube: a new model for pelvic serous carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Serous carcinogenesis in the fallopian tube: a descriptive classification.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype?

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

What is the true incidence of primary fallopian tube carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Are All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin?

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Incessant ovulation--a factor in ovarian neoplasia?

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

"Incessant ovulation" and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

The impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Risk factors for non-invasive lesions of the fallopian tube in BRCA mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Risk factors for a serous cancer precursor ("p53 signature") in women with inherited BRCA mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Prolonged postovulatory proinflammatory signaling in the fallopian tube epithelium may be mediated through a BRCA1/DAB2 axis

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Surveillance for the detection of recurrent ovarian cancer: survival impact or lead-time bias?

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Association between endometriosis and cancer: a comprehensive review and a critical analysis of clinical and epidemiological evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Can the pharmaceutical industry reduce attrition rates?

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Early events in the pathogenesis of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Gynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Survival patterns after oophorectomy in premenopausal women: a population-based cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Increased risk of parkinsonism in women who underwent oophorectomy before menopause.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Increased cardiovascular mortality after early bilateral oophorectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRT.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Total salpingectomy during abdominal hysterectomy: effects on ovarian reserve and ovarian stromal blood flow

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Survival in prospectively ascertained familial breast cancer: Analysis of a series stratified by tumour characteristics,BRCAmutations and oophorectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930659-9

7 January 2021

10.1016/S1701-2163(15)30659-9

Identifiers

DOI

1 reference

30 August 2017

1 reference